Cargando…

Prompt initiation of maintenance treatment following a COPD exacerbation: outcomes in a large insured population

BACKGROUND: The aim of this study was to extend previous findings and determine the value of prompt initiation of maintenance treatment (MT) following COPD exacerbations requiring hospitalization or an emergency department (ED) visit. PATIENTS AND METHODS: Administrative claims data (collected betwe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Coutinho, Anna D, Lokhandwala, Tasneem, Boggs, Robert L, Dalal, Anand A, Landsman-Blumberg, Pamela B, Priest, Julie, Stempel, David A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2016
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4907480/ https://www.ncbi.nlm.nih.gov/pubmed/27354781 http://dx.doi.org/10.2147/COPD.S102570

Ejemplares similares

Observational study of the outcomes and costs of initiating maintenance therapies in patients with moderate exacerbations of COPD
por: Dalal, Anand A, et al.
Publicado: (2012)

PRIMUS – Prompt Initiation of Maintenance Therapy in the US: A Real-World Analysis of Clinical and Economic Outcomes Among Patients Initiating Triple Therapy Following a COPD Exacerbation
por: Tkacz, Joseph, et al.
Publicado: (2022)

Use and cost comparison of clobazam to other antiepileptic drugs for treatment of Lennox-Gastaut syndrome
por: François, Clément, et al.
Publicado: (2017)

The role of fluticasone propionate/salmeterol combination therapy in preventing exacerbations of COPD
por: Yawn, Barbara P, et al.
Publicado: (2010)

Clinical and economic outcomes in an observational study of COPD maintenance therapies: multivariable regression versus propensity score matching
por: Roberts, Melissa H, et al.
Publicado: (2012)

Association between COPD exacerbations and lung function decline during maintenance therapy
por: Kerkhof, Marjan, et al.
Publicado: (2020)

Benefit of prompt initiation of single-inhaler fluticasone furoate, umeclidinium, and vilanterol (FF/UMEC/VI) in patients with COPD in England following an exacerbation: a retrospective cohort study
por: Ismaila, Afisi S., et al.
Publicado: (2023)

Exacerbations of COPD
por: Pavord, Ian D, et al.
Publicado: (2016)

Exacerbations of COPD
por: Viniol, Christian, et al.
Publicado: (2018)

Acute Exacerbations of COPD
por: Wedzicha, J.A.
Publicado: (2002)

Acute Exacerbations of COPD
por: Wedzicha, Jadwiga A.
Publicado: (2009)

Management of exacerbations of COPD
por: Seemungal, Terence, et al.
Publicado: (2003)

COPD affects worker productivity and health care costs
por: Patel, Jeetvan G, et al.
Publicado: (2018)

The Long-Term Burden of COPD Exacerbations During Maintenance Therapy and Lung Function Decline
por: Kerkhof, Marjan, et al.
Publicado: (2020)

Factors associated with health status and exacerbations in COPD maintenance therapy with dry powder inhalers
por: W. H. Kocks, Janwillem, et al.
Publicado: (2022)

Evaluation of Medication Adherence and Rescue Medication Use in Non-Exacerbating Patients with COPD Receiving Umeclidinium/Vilanterol or Budesonide/Formoterol as Initial Maintenance Therapy
por: Moretz, Chad, et al.
Publicado: (2020)

Benefit of Prompt versus Delayed Use of Single-Inhaler Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI) Following a COPD Exacerbation
por: Mannino, David, et al.
Publicado: (2022)

A systematic evaluation of the diagnostic criteria for COPD and exacerbations used in randomised controlled trials on the management of COPD exacerbations
por: Mathioudakis, Alexander G., et al.
Publicado: (2019)

Consolidation and Exacerbation of COPD
por: Hurst, John R.
Publicado: (2018)

Acute Exacerbation of COPD
por: Lief, Lindsay, et al.
Publicado: (2019)

Acute Exacerbation of COPD
por: Pappas, Dominic, et al.
Publicado: (2023)

Use of Antibiotics for Exacerbations of COPD
por: Daniels, Johannes M.A., et al.
Publicado: (2017)

Severity of COPD at initial spirometry-confirmed diagnosis: data from medical charts and administrative claims
por: Mapel, Douglas W, et al.
Publicado: (2011)

Initiation of triple therapy maintenance treatment among patients with COPD in the US
por: Simeone, Jason C, et al.
Publicado: (2016)

Effect of compliance with GOLD treatment recommendations on COPD health care resource utilization, cost, and exacerbations among patients with COPD on maintenance therapy
por: Palli, Swetha R, et al.
Publicado: (2021)

Validation of COPDPredict™: Unique Combination of Remote Monitoring and Exacerbation Prediction to Support Preventative Management of COPD Exacerbations
por: Patel, Neil, et al.
Publicado: (2021)

Cost trends among commercially insured and Medicare Advantage-insured patients with chronic obstructive pulmonary disease: 2006 through 2009
por: Dalal, Anand A, et al.
Publicado: (2011)

Deprivation, winter season, and COPD exacerbations
por: Donaldson, Gavin C, et al.
Publicado: (2013)

COPD exacerbations: defining their cause and prevention
por: Wedzicha, Jadwiga A, et al.
Publicado: (2007)

COPD exacerbation: Lost in translation
por: Makris, Demosthenes, et al.
Publicado: (2009)

Lung microbiology and exacerbations in COPD
por: Beasley, Victoria, et al.
Publicado: (2012)

Exacerbation frequency and course of COPD
por: Halpin, David MG, et al.
Publicado: (2012)

Exacerbations in COPD Patients with Bronchiectasis
por: Minov, Jordan, et al.
Publicado: (2017)

Impaired Hemorheology in Exacerbations of COPD
por: Ugurlu, Erhan, et al.
Publicado: (2017)

The airway microbiota and exacerbations of COPD
por: Leiten, Elise Orvedal, et al.
Publicado: (2020)

Models of infection and exacerbations in COPD
por: Papi, Alberto, et al.
Publicado: (2007)

Asymmetric Dimethylarginine in COPD Exacerbation
por: Ozkarafakili, Mufide Arzu, et al.
Publicado: (2022)

Prediction models for exacerbations in patients with COPD
por: Guerra, Beniamino, et al.
Publicado: (2017)

COPD Exacerbation-Related Pathogens and Previous COPD Treatment
por: Sim, Yun Su, et al.
Publicado: (2022)

Prompt initiation of triple therapy following hospitalization for a chronic obstructive pulmonary disease exacerbation in the United States: An analysis of the PRIMUS study
por: Evans, Kristin A, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_s3bdk4m55rkg2va3bcvf9mllvn